SOMAVERT
Posted Tuesday 10 June 2008 - 11:21 AM by David Chan (
MEDIUM
significance )
ATC Code
H01AX01
Warning
Pfizer, in consultation with Health Canada, wishes to inform you of an increased risk of marked hepatic enzyme elevations in patients taking SOMAVERT (pegvisomant) in combination with a somatostatin analogue (octreotide acetate).
SOMAVERT, a growth hormone receptor antagonist, is indicated for the treatment of acromegaly in patients who have had an inadequate response to surgery, and/or radiation therapy, and other medical therapies, or for whom these therapies are not appropriate.
No comments so far